Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study

Autor: Miauton, Alix, Audran, Régine, Besson, Juliette, Maby-El Hajjami, Hélène, Karlen, Maxime, Warpelin-Decrausaz, Loane, Sene, Loredana, Schaufelberger, Sylvain, Faivre, Vincent, Faouzi, Mohamed, Hartley, Mary-Anne, Spertini, François, Genton, Blaise
Zdroj: In eBioMedicine January 2024 99
Databáze: ScienceDirect